CORONA Remedies Limited (BOM:544644)
India · Delayed Price · Currency is INR 2,139.90
-24.60 (-1.14%)
At close: Aug 21, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 131.04 billion as of August 21, 2026.
Market Cap
131.04B
Enterprise Value
132.40B
Revenue
14.79B
Ranking
n/a
PE Ratio
65.84
Stock Price
2,139.90
ChartMarket Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 131.04B, an increase of 48.96%. That is a compound annual growth rate of 79.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 131.04B | 54.71% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 285.49B |
| Granules India | 212.72B |
| Caplin Point Laboratories | 194.45B |
| AstraZeneca Pharma India | 185.26B |
| Jubilant Pharmova | 139.25B |
| CORONA Remedies | 131.04B |
| Viyash Scientific | 120.57B |
| Procter & Gamble Health | 96.85B |